Julie Enevold Brooker will lead Johnson & Johnson Innovative Medicine Poland starting May 1, 2026, bringing over 20 years of pharmaceutical leadership experience.
New Leadership at Johnson & Johnson Innovative Medicine Poland
Julie Enevold Brooker has been appointed Managing Director of Johnson & Johnson Innovative Medicine in Poland, effective May 1, 2026.
Extensive Pharmaceutical Experience
Julie Enevold Brooker possesses more than 20 years of management experience within the pharmaceutical industry. She has a proven track record of implementing sustainable growth strategies, leading organizational transformations, and building high-performing teams.
Successful Tenure in Denmark
From 2020, Julie served as the Managing Director of Johnson & Johnson Innovative Medicine in Denmark. During her time there, she successfully transformed the Danish organization, attracting top talent and fostering a collaborative culture focused on employee development and efficiency.
Visionary in Life Sciences
Julie is widely recognized as a visionary within the Danish life science ecosystem. She played a key role in developing public-private partnerships, including the creation of the first public-private partnership with Denmark’s largest hospital.
Her managerial commitment to several industry organizations demonstrates a strong dedication to the broader healthcare agenda and improving patient outcomes.
Prior Roles at AstraZeneca and MSD
Prior to joining Johnson & Johnson, Julie held senior management positions at AstraZeneca and MSD, including leadership roles in the Scandinavian and Baltic regions, as well as other regional positions in Europe.
Succession and Company Overview
Julie, a Danish national and a graduate of the University of Southern Denmark, succeeds Geraldine Schenk, who has taken on the role of Managing Director for Turkey, Ukraine, Georgia, and Azerbaijan.
Johnson & Johnson believes that health is paramount and focuses on innovation to prevent complex diseases and develop smarter, less invasive therapies tailored to individual patient needs.
Copyright Information
Material is copyrighted and all rights are reserved. Further distribution requires permission from INFOR PL S.A. and a license purchase.